Not about to shout the bar, but another box ticked on the road to a killer product, and a hefty reward for shareholders.
- Forums
- ASX - By Stock
- NEU
- Ann: Trofinetide successful in Phase 2 trial in Fragile X
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.56%
!
$17.02

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.02 |
Change
-0.270(1.56%) |
Mkt cap ! $2.159B |
Open | High | Low | Value | Volume |
$17.08 | $17.67 | $16.97 | $5.112M | 295.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 83 | $17.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.03 | 1679 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 352 | 17.010 |
8 | 414 | 17.000 |
13 | 1340 | 16.990 |
5 | 596 | 16.980 |
5 | 1424 | 16.970 |
Price($) | Vol. | No. |
---|---|---|
17.030 | 218 | 7 |
17.040 | 745 | 5 |
17.050 | 583 | 6 |
17.060 | 688 | 8 |
17.070 | 563 | 7 |
Last trade - 15.10pm 01/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online